In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-04-18
NEOGNeogen CorpBoehm William TDirS - Sale$69.84-50010,480-5%-$34,920
D
2018-04-17
VRMLVermillion, Inc.Schuler Henri George10%P - Purchase$1.00+2,107,7749,262,363+29%+$2,107,774
D
2018-04-17
VRMLVermillion, Inc.Schuler Jack W10%P - Purchase$1.00+2,838,09013,416,342+27%+$2,838,090
2018-04-16
NEOGNeogen CorpHerbert James LExec COBS - Sale$68.50-20,0001,508,361-1%-$1,370,000
D
2018-04-10
NEOGNeogen CorpBoehm William TDirS - Sale+OE$67.94-1,0208,980-10%-$69,300
D
2018-04-06
NEOGNeogen CorpMorrical Terri AVPS - Sale+OE$67.78-14,80037,575-28%-$1,003,206
D
2018-04-03
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale+OE$15.30-27,313164,159-14%-$417,897
2018-04-03
ABIOArca Biopharma, Inc.Keuer Thomas ACOOS - Sale$0.50-48213,153-4%-$242
2018-04-02
ABIOArca Biopharma, Inc.Selby Brian L.VP, FinanceS - Sale$0.50-1,1140-100%-$556
2018-03-28
OCXOncocyte CorpBroadwood Partners, L.P.10%P - Purchase$1.26+3,968,25415,133,013+36%+$5,000,000
DM
2018-03-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$51.63-36,000294,313-11%-$1,858,740
D
2018-03-27
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$66.13-5,00013,470-27%-$330,648
D
2018-03-26
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$64.97-2,86613,470-18%-$186,213
2018-03-26
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.93+8,0003,160,5500%+$31,434
D
2018-03-23
NEOGNeogen CorpReed Thomas HDirS - Sale+OE$62.47-6,00013,375-31%-$374,818
2018-03-20
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$4.02+8,0003,152,5500%+$32,160
2018-03-20
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$23.87-39,2452,279,788-2%-$936,743
2018-03-14
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale$16.60-11,492164,159-7%-$190,775
2018-03-15
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.58+8,0003,144,5500%+$28,672
M
2018-03-07
IMMUImmunomedics IncGoldenberg David MDirS - Sale$17.41-117,7297,387,537-2%-$2,049,389
2018-03-09
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.48+8,0003,136,5500%+$27,864
D
2018-02-28
IDXXIdexx Laboratories Inc /deJunius Daniel MDirS - Sale+OE$190.06-2,9742,628-53%-$565,232
2018-02-28
ABIOArca Biopharma, Inc.Keuer Thomas ACOOS - Sale$0.72-41013,635-3%-$294
2018-02-27
ABIOArca Biopharma, Inc.Selby Brian L.VP, FinanceS - Sale$0.53-1611,114-13%-$85
DM
2018-02-26
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$44.32-36,000290,843-11%-$1,595,520
M
2018-02-26
ABIOArca Biopharma, Inc.Venrock Healthcare Capital Partners LP10%S - Sale$0.55-1,541,3310-100%-$846,905
2018-02-26
LNTHLantheus Holdings, Inc.Healey Timothy GSVP, CommercialS - Sale$19.58-3,69660,886-6%-$72,358
2018-02-26
ABIOArca Biopharma, Inc.Sonsini Peter W.10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Sandell Scott D10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Sakoda Jon10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Mott David M10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Makower Joshua10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Florence Anthony A. Jr.10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Baskett Forest10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Barris Peter J10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Growth Equity Opportunities Iv, LLC10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-23
VIVOMeridian Bioscience IncMcIlwraith JohnDirP - Purchase$14.03+1,0004,000+33%+$14,034
2018-02-22
IDXXIdexx Laboratories Inc /deEnd William TDirS - Sale$184.49-4,00041,256-9%-$737,939
2018-02-21
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.23+6,0003,128,5500%+$19,373
D
2018-02-21
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$60.15-2,00013,470-13%-$120,294
DM
2018-02-20
NEOGNeogen CorpHerbert James LExec COBS - Sale+OE$59.32-25,3341,150,926-2%-$1,502,879
D
2018-02-21
QTNTQuotient LtdVon Prondzynski HeinoDirP - Purchase$4.28+12,00073,229+20%+$51,348
M
2018-02-16
NEOGNeogen CorpBradley EdwardVP (Retired)S - Sale$59.60-7,0009,958-41%-$417,223
2018-02-16
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.27+7,0003,122,5500%+$22,921
2018-02-15
NEOGNeogen CorpHerbert James LExec COBS - Sale$57.50-10,0001,528,361-1%-$574,954
2018-02-14
IDXXIdexx Laboratories Inc /deKingsley Lawrence DDirP - Purchase$178.04+1,0004,558+28%+$178,045
DM
2018-02-15
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale+OE$12.01-3,00015,000-17%-$36,038
2018-02-12
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.27+8,0003,115,5500%+$26,161
D
2018-02-08
QTNTQuotient LtdMcDonough BrianDirP - Purchase$3.87+10,00047,747+26%+$38,680
2018-02-09
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.18+7,0003,107,5500%+$22,254
2018-02-07
IDXXIdexx Laboratories Inc /deClaflin Bruce L.DirP - Purchase$179.58+1,0001,000New+$179,580
DM
2018-02-07
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$177.52-22,0001,157,112-2%-$3,905,383
2018-02-08
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.37+10,0003,100,5500%+$33,717
D
2018-02-05
IDXXIdexx Laboratories Inc /deMcKeon Brian PEVP, CFOS - Sale+OE$181.37-6,60240,438-14%-$1,197,369
DM
2018-02-05
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$179.28-36,0001,157,112-3%-$6,453,974
2018-02-07
VIVOMeridian Bioscience IncRice John McCune Jr.DirP - Purchase$14.75+1,0001,000New+$14,750
2018-02-02
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.47+5,0003,090,5500%+$17,350
DM
2018-01-29
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$46.95-36,000274,493-12%-$1,690,320
2018-01-29
NTLAIntellia Therapeutics, Inc.Caribou Biosciences, Inc.10%S - Sale$26.78-550,6453,994,355-12%-$14,746,273
M
2018-01-26
NEOGNeogen CorpBradley EdwardVP (Retired)S - Sale$60.29-11,7259,787-55%-$706,950
2018-01-26
NEOGNeogen CorpPapesh G BruceDirS - Sale$59.72-6,00018,196-25%-$358,320
2018-01-22
QDELQuidel Corp /de/Schuler Jack WDir, 10%S - Sale$48.50-12,0003,414,0530%-$582,031
D
2018-01-22
MYGNMyriad Genetics IncKing Gary A.EVP International OpsS - Sale+OE$39.67-34,445121,968-22%-$1,366,588
D
2018-01-22
MYGNMyriad Genetics IncMarsh Richard ME.VP, GCS - Sale+OE$40.25-37,654123,769-23%-$1,515,611
2018-01-18
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.14+3,0003,085,5500%+$9,415
D
2018-01-18
MYGNMyriad Genetics IncMarsh Richard ME.VP, GCS - Sale+OE$38.25-40,000119,994-25%-$1,530,000
D
2018-01-18
MYGNMyriad Genetics IncKing Gary A.EVP International OpsS - Sale+OE$38.12-3,120121,968-2%-$118,934
2018-01-16
LNTHLantheus Holdings, Inc.Crowley John W.CFOS - Sale$23.52-3,866138,656-3%-$90,914
D
2018-01-16
IONSIonis Pharmaceuticals IncHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$51.76-2,72414,500-16%-$140,994
2018-01-12
MYGNMyriad Genetics IncMarsh Richard ME.VP, GCS - Sale$36.25-13,759119,994-10%-$498,764
D
2018-01-10
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale+OE$22.40-21,655152,301-12%-$485,111
DM
2018-01-09
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$165.98-54,0001,157,112-4%-$8,962,773
2018-01-05
QDELQuidel Corp /de/Schuler Jack WDir, 10%S - Sale$47.02-4,0003,426,0530%-$188,080
DM
2018-01-03
QDELQuidel Corp /de/Borkar Ratan SSVP, Intl Comm OperationsS - Sale+OE$45.15-29,8807,642-80%-$1,349,203
DM
2017-12-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$44.10-36,000274,493-12%-$1,587,720
2017-12-29
RIOTRiot Blockchain, Inc.O'Rourke John R. IIIPres, CEO, COBS - Sale$28.61-30,38352,000-37%-$869,256
M
2017-12-20
QDELQuidel Corp /de/Schuler Jack WDir, 10%S - Sale$44.60-4,0003,365,0530%-$178,400
D
2017-12-15
IONSIonis Pharmaceuticals IncHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$52.55-5,00010,392-32%-$262,750
D
2017-12-15
QDELQuidel Corp /de/Bujarski Robert JosephSVP, Bus Dev, GCS - Sale+OE$39.78-110,70437,759-75%-$4,403,290
2017-12-14
MYGNMyriad Genetics IncGilbert Walter PhdDirS - Sale$33.19-7,50027,243-22%-$248,925
D
2017-12-12
QDELQuidel Corp /de/Steward Randall JCFOS - Sale+OE$40.09-36,38319,907-65%-$1,458,594
D
2017-12-08
QDELQuidel Corp /de/Kroll WernerSVP, R, DS - Sale+OE$40.44-16,3583,718-81%-$661,529
2017-12-11
MYGNMyriad Genetics IncDreismann HeinrichDirS - Sale$33.50-6,00033,743-15%-$201,000
M
2017-12-06
NTLAIntellia Therapeutics, Inc.Bermingham NessanPres, CEOS - Sale$20.79-336,783458,250-42%-$7,000,019
D
2017-12-05
QDELQuidel Corp /de/Kroll WernerSVP, R, DS - Sale+OE$40.51-13,5363,718-78%-$548,343
D
2017-12-05
QDELQuidel Corp /de/Brown Thomas DDirS - Sale+OE$39.62-12,15445,025-21%-$481,541
D
2017-12-04
QDELQuidel Corp /de/Borkar Ratan SSVP, Intl Comm OperationsS - Sale+OE$40.05-24,7817,642-76%-$992,479
D
2017-12-04
IONSIonis Pharmaceuticals IncHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$57.00-4,00010,392-28%-$228,000
2017-11-30
IDXXIdexx Laboratories Inc /deTwigge GiovaniCHROS - Sale$156.07-2,00014,402-12%-$312,137
D
2017-11-29
IONSIonis Pharmaceuticals IncHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$53.02-6,00010,392-37%-$318,120
DM
2017-11-28
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$37.36-36,000284,493-11%-$1,345,080
D
2017-11-20
IMMUImmunomedics IncMarkison Brian ADirS - Sale+OE$11.89-8,39090,788-8%-$99,724
D
2017-11-17
NEOGNeogen CorpBradley EdwardVPS - Sale+OE$80.32-17,82421,512-45%-$1,431,624
D
2017-11-16
IONSIonis Pharmaceuticals IncHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$54.35-7,00010,392-40%-$380,450
2017-11-17
LNTHLantheus Holdings, Inc.Healey Timothy GSVP, CommercialS - Sale$21.51-11,31466,362-15%-$243,400
DM
2017-11-14
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$150.52-54,0001,144,573-5%-$8,128,136
D
2017-11-14
NEOGNeogen CorpHerbert James LExec COBS - Sale+OE$81.29-18,000873,005-2%-$1,463,287
2017-11-15
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$1.46+68561,963+1%+$1,000
2017-11-14
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale$21.63-11,917152,301-7%-$257,787
M
2017-11-14
IMMUImmunomedics IncVenbio Select Advisor LLCSee Remarks, 10%P - Purchase$10.47+1,325,00031,953,922+4%+$13,868,250

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top